Laura Ferrari

1.1k total citations
26 papers, 669 citations indexed

About

Laura Ferrari is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Laura Ferrari has authored 26 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Laura Ferrari's work include Cancer, Hypoxia, and Metabolism (6 papers), Adrenal and Paraganglionic Tumors (6 papers) and Glioma Diagnosis and Treatment (4 papers). Laura Ferrari is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Adrenal and Paraganglionic Tumors (6 papers) and Glioma Diagnosis and Treatment (4 papers). Laura Ferrari collaborates with scholars based in Italy, United States and Germany. Laura Ferrari's co-authors include Alfredo Berruti, Edda Simoncini, Fabio Gallo, Valentina Bertaglia, Alberto Bottini, Vito Amoroso, Maria Pia Sormani, Paolo Bruzzi, Massimo Terzolo and Barbara Zaggia and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Laura Ferrari

26 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Ferrari Italy 11 307 299 157 125 93 26 669
Anna Pecorelli Italy 14 143 0.5× 153 0.5× 159 1.0× 110 0.9× 117 1.3× 44 1.1k
Yoriko De Sanctis United States 9 175 0.6× 115 0.4× 127 0.8× 91 0.7× 101 1.1× 25 738
Deniz Tural Türkiye 17 478 1.6× 143 0.5× 217 1.4× 377 3.0× 107 1.2× 121 938
Federica Vianello Italy 18 142 0.5× 148 0.5× 174 1.1× 64 0.5× 98 1.1× 44 828
Anna Efremidis Greece 21 602 2.0× 134 0.4× 76 0.5× 420 3.4× 85 0.9× 59 1.0k
Talal Hilal United States 15 203 0.7× 104 0.3× 76 0.5× 136 1.1× 130 1.4× 71 700
Kenji Yokoyama Japan 15 149 0.5× 45 0.2× 166 1.1× 66 0.5× 117 1.3× 57 820
Chuan Li China 20 344 1.1× 338 1.1× 404 2.6× 182 1.5× 65 0.7× 97 1.3k
Akin Inderson Netherlands 15 215 0.7× 110 0.4× 220 1.4× 147 1.2× 36 0.4× 46 637
A Ippolito Italy 19 196 0.6× 136 0.5× 448 2.9× 144 1.2× 36 0.4× 40 1.4k

Countries citing papers authored by Laura Ferrari

Since Specialization
Citations

This map shows the geographic impact of Laura Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Ferrari more than expected).

Fields of papers citing papers by Laura Ferrari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Ferrari. The network helps show where Laura Ferrari may publish in the future.

Co-authorship network of co-authors of Laura Ferrari

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Ferrari. A scholar is included among the top collaborators of Laura Ferrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Ferrari. Laura Ferrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrari, Laura, Camilla Ferrari, Chiara Vismara, et al.. (2024). Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes—a retrospective observational study. Internal and Emergency Medicine. 20(2). 573–583. 3 indexed citations
2.
Grisanti, Salvatore, Deborah Cosentini, Marta Laganà, et al.. (2021). Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy. Frontiers in Endocrinology. 12. 624102–624102. 7 indexed citations
3.
Piva, Simone, Matteo Filippini, Sergio Cattaneo, et al.. (2020). Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. Journal of Critical Care. 58. 29–33. 113 indexed citations
4.
Roca, Elisa, Alfredo Berruti, Silviu Sbiera, et al.. (2017). Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer. Endocrine Related Cancer. 24(7). 319–327. 28 indexed citations
5.
Cremolini, Chiara, Carlotta Antoniotti, Fotios Loupakis, et al.. (2016). Modified FOLFOXIRI (mFOLFOXIRI) plus cetuximab (cet), followed by cet or bevacizumab (bev) maintenance, in RAS/BRAF wt metastatic colorectal cancer (mCRC): The phase II randomized MACBETH trial by GONO. Annals of Oncology. 27. vi152–vi152. 3 indexed citations
6.
Ferrari, Laura, Mélanie Claps, Salvatore Grisanti, & Alfredo Berruti. (2015). Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update. European Urology Focus. 1(3). 298–300. 5 indexed citations
7.
Aprile, Giuseppe, Elena Ongaro, Marzia Del Re, et al.. (2015). Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight. Critical Reviews in Oncology/Hematology. 95(2). 165–178. 19 indexed citations
8.
9.
Aprile, Giuseppe, Caterina Fontanella, Marta Bonotto, et al.. (2015). Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials. Oncotarget. 6(30). 28716–28730. 10 indexed citations
10.
Terzolo, Massimo, Silvia De Francia, Arianna Ardito, et al.. (2014). A current perspective on treatment of adrenocortical carcinoma. Expert Opinion on Orphan Drugs. 2(9). 911–921. 2 indexed citations
11.
Grisanti, Salvatore, Camillo Almici, Francesca Consoli, et al.. (2014). Circulating Tumor Cells in Patients with Recurrent or Metastatic Head and Neck Carcinoma: Prognostic and Predictive Significance. PLoS ONE. 9(8). e103918–e103918. 68 indexed citations
12.
Terzolo, Massimo, Fulvia Daffara, Arianna Ardito, et al.. (2014). Management of adrenal cancer: a 2013 update. Journal of Endocrinological Investigation. 37(3). 207–217. 72 indexed citations
13.
Ferrari, Laura, Salvatore Grisanti, Sandra Sigala, et al.. (2014). Molecular Target Agents in Adrenocortical Carcinoma: Rationale and Difficulties in Trial Design. Institutional Research Information System (Università degli Studi di Brescia). 1(1). 31–34. 1 indexed citations
14.
Birocchi, Simone, et al.. (2013). Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies. Internal and Emergency Medicine. 8(8). 757–760. 5 indexed citations
15.
Milan, Alberto, et al.. (2013). Arterial hypertension and cancer. International Journal of Cancer. 134(10). 2269–2277. 57 indexed citations
16.
Aprile, Giuseppe, Laura Ferrari, Caterina Fontanella, & Fabio Puglisi. (2012). Bevacizumab in older patients with advanced colorectal or breast cancer. Critical Reviews in Oncology/Hematology. 87(1). 41–54. 10 indexed citations
17.
Racca, Patrizia, Rosella Spadi, Laura Fanchini, et al.. (2012). Hemolytic uremic syndrome induced by infusion of oxaliplatin: a case report.. PubMed. 97(5). 31e–3e. 7 indexed citations
18.
Belli, Carmen, Stefano Cereda, Anna Novarino, et al.. (2012). Clinical and Translational Results of a Phase II Randomized Trial of Maintenance Sunitinib or Observation in Metastatic Pancreatic Adenocarcinoma. Università degli Studi di Napoli Federico II. 13. 551–551. 2 indexed citations
19.
Racca, Patrizia, Rosella Spadi, Laura Fanchini, et al.. (2011). Hemolytic uremic syndrome induced by infusion of oxaliplatin: A case report. Tumori Journal. 97(5). e31–e33. 8 indexed citations
20.
Daidone, Maria Grazia, Silvia Veneroni, Elvira Benini, et al.. (1999). Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer. International Journal of Cancer. 84(6). 580–586. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Pecorelli Breakdown of academic impact, for papers by Yoriko De Sanctis Breakdown of academic impact, for papers by Deniz Tural Breakdown of academic impact, for papers by Federica Vianello Breakdown of academic impact, for papers by Anna Efremidis Breakdown of academic impact, for papers by Talal Hilal Breakdown of academic impact, for papers by Kenji Yokoyama Breakdown of academic impact, for papers by Chuan Li Breakdown of academic impact, for papers by Akin Inderson Breakdown of academic impact, for papers by A Ippolito
Rankless by CCL
2026